AUB ScholarWorks

Spread of OXA-48-encoding plasmid in Turkey and beyond

Show simple item record Carrer A. Poirel L. Yilmaz M. Akan O.A. Feriha C. Cuzon G. Matar G. Honderlick P. Nordmann P.
dc.contributor.editor Mar-2010 2017-10-05T15:35:25Z 2017-10-05T15:35:25Z 2010
dc.identifier 10.1128/AAC.01312-09
dc.identifier.issn 00664804
dc.description.abstract Eighteen carbapenem-resistant, OXA-48-positive enterobacterial isolates recovered from Turkey, Lebanon, Egypt, France, and Belgium were analyzed. In most isolates, similar 70-kb plasmids carrying the carbapenemase gene bla OXA-48 were identified. That gene was located within either transposon Tn1999 or transposon Tn1999.2, which was always inserted within the same gene. This work highlights the current plasmid-mediated dissemination of the OXA-48 carbapenemase worldwide. Copyright © 2010, American Society for Microbiology. All Rights Reserved.
dc.format.extent Pages: (1369-1373)
dc.language English
dc.publisher WASHINGTON
dc.relation.ispartof Publication Name: Antimicrobial Agents and Chemotherapy; Publication Year: 2010; Volume: 54; no. 3; Pages: (1369-1373);
dc.source Scopus
dc.title Spread of OXA-48-encoding plasmid in Turkey and beyond
dc.type Article
dc.contributor.affiliation Carrër, A., Service de Bactériologie-Virologie, INSERM U914 Emerging Resistance to Antibiotics, Hôpital de Bicêtre, K.-Bicêtre, France
dc.contributor.affiliation Poirel, L., Service de Bactériologie-Virologie, INSERM U914 Emerging Resistance to Antibiotics, Hôpital de Bicêtre, K.-Bicêtre, France
dc.contributor.affiliation Yilmaz, M., Infectious Diseases and Clinical Microbiology Department, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
dc.contributor.affiliation Akan, Ö.A., Medical School, Ankara University, Ibni Sina Hospital, Ankara, Turkey
dc.contributor.affiliation Feriha, C., Ege University Medical Faculty, Department of Microbiology and Clinical Microbiology, Izmir, Turkey
dc.contributor.affiliation Cuzon, G., Service de Bactériologie-Virologie, INSERM U914 Emerging Resistance to Antibiotics, Hôpital de Bicêtre, K.-Bicêtre, France
dc.contributor.affiliation Matar, G., American University of Beirut, Beirut, Lebanon
dc.contributor.affiliation Honderlick, P., Service de Microbiologie, Hôpital Foch, Suresnes, France
dc.contributor.affiliation Nordmann, P., Service de Bactériologie-Virologie, INSERM U914 Emerging Resistance to Antibiotics, Hôpital de Bicêtre, K.-Bicêtre, France
dc.contributor.authorAddress Nordmann, P.; Service de Bactériologie-Virologie, INSERM U914 Emerging Resistance to Antibiotics, Hôpital de Bicêtre, K.-Bicêtre, France; email:
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Experimental Pathology, Immunology and Microbiology;
dc.contributor.authorDepartment Experimental Pathology, Immunology and Microbiology
dc.contributor.authorFaculty Faculty of Medicine
dc.contributor.authorInitials Carrer, A
dc.contributor.authorInitials Poirel, L
dc.contributor.authorInitials Yilmaz, M
dc.contributor.authorInitials Akan, OA
dc.contributor.authorInitials Feriha, C
dc.contributor.authorInitials Cuzon, G
dc.contributor.authorInitials Matar, G
dc.contributor.authorInitials Honderlick, P
dc.contributor.authorInitials Nordmann, P
dc.contributor.authorReprintAddress Nordmann, P (reprint author), Hop Bicetre, Serv Bacteriol Virol, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited Aktas Z, 2008, CHEMOTHERAPY, V54, P101, DOI 10.1159-000118661; AMUTHAN G, 1994, PLASMID, V32, P328, DOI 10.1006-plas.1994.1072; Aubert D, 2006, J BACTERIOL, V188, P6506, DOI 10.1128-JB.00375-06; Bell JM, 2009, 49 INT C ANT AG CHEM; Bonnet R, 2002, ANTIMICROB AGENTS CH, V46, P2004, DOI 10.1128-AAC.46.6.2004-2006.2002; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016-j.mimet.2005.03.018; Carrer A, 2008, ANTIMICROB AGENTS CH, V52, P2950, DOI 10.1128-AAC.01672-07; CASTANHEIRA M, 2009, 49 INT C ANT AG CHEM; Clinical and Laboratory Standards Institute, 2008, M100S18 CLIN LAB STA; CUZON G, 2009, 49 INT C ANT AG CHEM; Cuzon G, 2008, ANTIMICROB AGENTS CH, V52, P3463, DOI 10.1128-AAC.00543-08; Elumalai R. P., 1997, Indian Journal of Experimental Biology, V35, P408; Girlich D, 2007, APPL ENVIRON MICROB, V73, P4681, DOI 10.1128-AEM.02491-06; Gulmez D, 2008, INT J ANTIMICROB AG, V31, P523, DOI 10.1016-j.ijantimicag.2008.01.017; JARLIER V, 1988, REV INFECT DIS, V10, P867; KIESER T, 1984, PLASMID, V12, P19, DOI 10.1016-0147-619X(84)90063-5; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093-jac-dkp255; Matar GM, 2008, CLIN MICROBIOL INFEC, V14, P887, DOI 10.1111-j.1469-0691.2008.02059.x; Nazic H, 2005, ANTIMICROB AGENTS CH, V49, P2146, DOI 10.1128-AAC.49.5.2146-2147.2005; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016-S1473-3099(09)70054-4; Nordmann P, 2002, CLIN MICROBIOL INFEC, V8, P321, DOI 10.1046-j.1469-0691.2002.00401.x; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128-AAC.48.1.15-22.2004; Poirel L, 2007, FUTURE MICROBIOL, V2, P501, DOI 10.2217-17460913.2.5.501; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P348, DOI 10.1128-AAC.48.1.348-351.2004; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128-AAC.01512-08; TANIMOTO K, 1985, MOL GEN GENET, V198, P356, DOI 10.1007-BF00383019; Thomas CP, 2009, 49 INT C ANT AG CHEM; TOP E, 1994, APPL ENVIRON MICROB, V60, P831
dc.description.citedCount 112
dc.description.citedTotWOSCount 110
dc.description.citedWOSCount 109
dc.format.extentCount 5
dc.identifier.coden AMACC
dc.identifier.pubmedID 20086157
dc.identifier.scopusID 77149120744
dc.publisher.address 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
dc.relation.ispartOfISOAbbr Antimicrob. Agents Chemother.
dc.relation.ispartOfIssue 3
dc.relation.ispartofPubTitle Antimicrobial Agents and Chemotherapy
dc.relation.ispartofPubTitleAbbr Antimicrob. Agents Chemother.
dc.relation.ispartOfVolume 54
dc.source.ID WOS:000274733300064
dc.type.publication Journal
dc.subject.otherChemCAS amoxicillin, 26787-78-0, 34642-77-8, 61336-70-7
dc.subject.otherChemCAS amoxicillin plus clavulanic acid, 74469-00-4, 79198-29-1
dc.subject.otherChemCAS aztreonam, 78110-38-0
dc.subject.otherChemCAS cefalotin, 153-61-7, 58-71-9
dc.subject.otherChemCAS cefepime, 88040-23-7
dc.subject.otherChemCAS cefotaxime, 63527-52-6, 64485-93-4
dc.subject.otherChemCAS cefoxitin, 33564-30-6, 35607-66-0
dc.subject.otherChemCAS ceftazidime, 72558-82-8
dc.subject.otherChemCAS ertapenem, 153773-82-1, 153832-38-3, 153832-46-3
dc.subject.otherChemCAS imipenem, 64221-86-9
dc.subject.otherChemCAS meropenem, 96036-03-2
dc.subject.otherChemCAS piperacillin, 59703-84-3, 61477-96-1
dc.subject.otherChemCAS ticarcillin, 29457-07-6, 34787-01-4, 4697-14-7
dc.subject.otherChemCAS timentin, 86482-18-0
dc.subject.otherChemCAS Anti-Bacterial Agents
dc.subject.otherChemCAS Carbapenems
dc.subject.otherChemCAS DNA Transposable Elements
dc.subject.otherChemCAS beta-Lactamases,
dc.subject.otherChemCAS oxacillinase,
dc.subject.otherIndex amoxicillin
dc.subject.otherIndex amoxicillin plus clavulanic acid
dc.subject.otherIndex antibiotic agent
dc.subject.otherIndex aztreonam
dc.subject.otherIndex carbapenem derivative
dc.subject.otherIndex cefalotin
dc.subject.otherIndex cefepime
dc.subject.otherIndex cefotaxime
dc.subject.otherIndex cefoxitin
dc.subject.otherIndex ceftazidime
dc.subject.otherIndex ertapenem
dc.subject.otherIndex imipenem
dc.subject.otherIndex meropenem
dc.subject.otherIndex oxacillinase 23
dc.subject.otherIndex piperacillin
dc.subject.otherIndex piperacillin plus tazobactam
dc.subject.otherIndex ticarcillin
dc.subject.otherIndex timentin
dc.subject.otherIndex unclassified drug
dc.subject.otherIndex article
dc.subject.otherIndex bacterium isolate
dc.subject.otherIndex Belgium
dc.subject.otherIndex Egypt
dc.subject.otherIndex France
dc.subject.otherIndex gene mutation
dc.subject.otherIndex Lebanon
dc.subject.otherIndex minimum inhibitory concentration
dc.subject.otherIndex nonhuman
dc.subject.otherIndex plasmid
dc.subject.otherIndex polymerase chain reaction
dc.subject.otherIndex priority journal
dc.subject.otherIndex pulsed field gel electrophoresis
dc.subject.otherIndex transposon
dc.subject.otherIndex Turkey (republic)
dc.subject.otherIndex Anti-Bacterial Agents
dc.subject.otherIndex Belgium
dc.subject.otherIndex beta-Lactam Resistance
dc.subject.otherIndex beta-Lactamases
dc.subject.otherIndex Carbapenems
dc.subject.otherIndex DNA Transposable Elements
dc.subject.otherIndex Egypt
dc.subject.otherIndex Enterobacteriaceae
dc.subject.otherIndex Enterobacteriaceae Infections
dc.subject.otherIndex France
dc.subject.otherIndex Humans
dc.subject.otherIndex Lebanon
dc.subject.otherIndex Microbial Sensitivity Tests
dc.subject.otherIndex Plasmids
dc.subject.otherIndex Turkey
dc.subject.otherKeywordPlus D BETA-LACTAMASE
dc.subject.otherKeywordPlus KLEBSIELLA-PNEUMONIAE
dc.subject.otherKeywordPlus ESCHERICHIA-COLI
dc.subject.otherKeywordPlus MEDIATED RESISTANCE
dc.subject.otherKeywordPlus IDENTIFICATION
dc.subject.otherKeywordPlus ENTEROBACTERIACEAE
dc.subject.otherKeywordPlus ISTANBUL
dc.subject.otherKeywordPlus IMIPENEM
dc.subject.otherKeywordPlus OXA-48
dc.subject.otherWOS Microbiology
dc.subject.otherWOS Pharmacology and Pharmacy

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


My Account